Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Skarke

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Research Square|February 24, 2023
Diurnal rhythmicity of wearable device-measured wrist temperature predicts future disease incidence in the UK BiobankCarsten Skarke, Thomas Brooks, Nicholas Lahens, et al.
PLOS Digital Health|May 23, 2024
Using routinely collected clinical data for circadian medicine: A review of opportunities and challengesLaura Kervezee, Hassan S Dashti, Luísa K Pilz, et al.
Sleep|October 23, 2024
Genetic variants associated with chronic fatigue syndrome predict population-level fatigue severity and actigraphic measurementsPatrick Z Liu, David M Raizen, Carsten Skarke, et al.
The American Journal of Psychiatry|November 5, 2003
Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniquesJürgen M Peters, Thomas Hummel, Tilman Kratzsch, et al.
Pharmacogenetics|October 30, 2003
Effects of ABCB1 (multidrug resistance transporter) gene mutations on disposition and central nervous effects of loperamide in healthy volunteersCarsten Skarke, Marwan Jarrar, Helmut Schmidt, et al.
Clinical Pharmacology and Therapeutics|January 18, 2006
Evidence for morphine-independent central nervous opioid effects after administration of codeine: contribution of other codeine metabolitesJörn Lötsch, Carsten Skarke, Helmut Schmidt, et al.
Clinical Pharmacology and Therapeutics|December 21, 2006
The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 productionCarsten Skarke, Maximilian Reus, Ronald Schmidt, et al.
European Journal of Pharmacology|April 21, 2009
On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevanceUlf Siemoneit, Carlo Pergola, Bianca Jazzar, et al.
Anesthesiology|October 3, 2002
Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?Jörn Lötsch, Michael Zimmermann, Jutta Darimont, et al.
Clinical Pharmacology and Therapeutics|January 18, 2006
Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug actionJörn Lötsch, Carsten Skarke, Johannes Wieting, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Research Square|February 24, 2023
Diurnal rhythmicity of wearable device-measured wrist temperature predicts future disease incidence in the UK BiobankCarsten Skarke, Thomas Brooks, Nicholas Lahens, et al.
PLOS Digital Health|May 23, 2024
Using routinely collected clinical data for circadian medicine: A review of opportunities and challengesLaura Kervezee, Hassan S Dashti, Luísa K Pilz, et al.
Sleep|October 23, 2024
Genetic variants associated with chronic fatigue syndrome predict population-level fatigue severity and actigraphic measurementsPatrick Z Liu, David M Raizen, Carsten Skarke, et al.
The American Journal of Psychiatry|November 5, 2003
Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniquesJürgen M Peters, Thomas Hummel, Tilman Kratzsch, et al.
Pharmacogenetics|October 30, 2003
Effects of ABCB1 (multidrug resistance transporter) gene mutations on disposition and central nervous effects of loperamide in healthy volunteersCarsten Skarke, Marwan Jarrar, Helmut Schmidt, et al.
Clinical Pharmacology and Therapeutics|January 18, 2006
Evidence for morphine-independent central nervous opioid effects after administration of codeine: contribution of other codeine metabolitesJörn Lötsch, Carsten Skarke, Helmut Schmidt, et al.
Clinical Pharmacology and Therapeutics|December 21, 2006
The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 productionCarsten Skarke, Maximilian Reus, Ronald Schmidt, et al.
European Journal of Pharmacology|April 21, 2009
On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevanceUlf Siemoneit, Carlo Pergola, Bianca Jazzar, et al.
Anesthesiology|October 3, 2002
Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?Jörn Lötsch, Michael Zimmermann, Jutta Darimont, et al.
Clinical Pharmacology and Therapeutics|January 18, 2006
Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug actionJörn Lötsch, Carsten Skarke, Johannes Wieting, et al.
Pageof 7